Table 1.
Characteristics of study participants
| Mean (SD) | Median | Range | N | |
|---|---|---|---|---|
| Age at Screening (Years) | 16.85 (2.11) | 16.83 | 12.25–22.70 | 197 |
| Sex (% Male) | 56.85 | - | - | 197 |
| Race | 197 | |||
| % Black | 49.24% | - | - | |
| % Non-Hispanic White | 22.84% | |||
| % Other Race/ethnicity | 27.91% | |||
| Insurance (% Public) | 59.69 | - | - | 196 |
| Diabetes Duration (Years) | 3.42 (2.79) | 2.52 | 0.5–14.67 | 196 |
| On Insulin Only (%) | 17.35 | 196 | ||
| Oral Medication Only (%) | 31.63 | 196 | ||
| On Insulin and Oral Medication (%) | 45.92 | 196 | ||
| A1C (%) A1C (mmol/mol) |
8.56 (2.61) 70 |
8.00 64 |
4.6–14.0 27–130 |
194 |
| BMI (kg/m2) | 37.56 (8.23) | 36.64 | 21.01–63.62 | 98 |
| Average BG Level (mg/dL) | 188.33 (79.88) | 170 | 0–425 | 100 |
| DKA Events (%) | 1.02 (0.12) | 197 | ||
| Diabetes Hospitalizations (% with 1 or more) | 11.16 | 197 | ||
| Clinic Visits (n/year) | 2.46 (1.44) | 2 | 0–7 | 197 |
| BG Checks (n/day) | 1.31 (1.15) | 1.00 | 0.07–4.93 | 103 |
| PHQ | 4.52 (5.16) | 2 | 0–21 | 197 |